The Chicago AYA Oncology Symposium: Breakthroughs in Treatment for Adolescents and Young Adults with Leukemia
Learn more by visiting the Chicago AYA website here.
At the conclusion of this activity, the learner will be able to:
- Identify a rationale and mechanism for treating young adults with blood cancers in a specialized clinic;
- Examine new strategies for treatment of young adults with acute lymphoblastic leukemia including CAR T-cells and other new immunotherapeutic approaches;
- Define the importance and goals of survivorship for young adults with malignancies;
- Discuss insights into the unique challenges facing young adults with leukemia.
*Program agenda and speaker selection subject to change.
Click here to learn more about The University of Chicago Gleacher Center!
ACCESSIBILITY The University of Chicago is committed to providing equal access appropriate to need and circumstances and complies fully with legal requirements of the Americans with Disabilities Act. If you are in need of special accommodation, please contact our office at 219-465-1115 or via email at email@example.com.
The University of Chicago reserves the right to cancel or postpone this conference due to unforeseen circumstances. In the unlikely event this activity must be cancelled or postponed, the registration fee will be refunded; however, The University of Chicago is not responsible for any related costs, charges, or expenses to participants, including fees assessed by airline/travel/lodging agencies.
Professor of Medicine
Director, Hematologic Malignancies Program
Anjuli Seth Nayak Professor in Leukemia
Associate Professor of Pediatrics
Director, Childhood Cancer Survivors Center
As a provider accredited by the ACCME, The University of Chicago Pritzker School of Medicine asks everyone who is in a position to control the content of an education activity to disclose all relevant financial relationships with any commercial interest. This includes any entity producing, marketing, re-selling, or distributing health care goods or services consumed by or used on patients. The ACCME defines “relevant financial relationships” as financial relationships in any amount occurring within the past 12 months, including financial relationships of a spouse or life partner that could create a conflict of interest. Mechanisms are in place to identify and resolve any potential conflict of interest prior to the start of the activity.
Additionally, The University of Chicago Pritzker School of Medicine requires authors to identify investigational products or off-label uses of products regulated by the US Food and Drug Administration, at first mention and where appropriate in the content.
Other Health Professions Credit